Tiziana reports excellent safety profile with intranasal foralumab after 37.4 patient-years cumulative exposureFDA denial of Sanofi’s tolebrutinib for nrSPMS shows need for safe therapy BOSTON, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the submission of its seventh annual Development Safety Update Report (DSUR) to the U.S. Food an ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) ("Enveric†or the "Company†), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced the issuance of U.S. Patent No. 12,492,179 entitled, "Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives†(the "'179 patent†), with claims to compositions and methods of treatment for novel molecules with the potential to be developed. ...

Toronto, Ontario--(Newsfile Corp. - December 29, 2025) - NINE MILE METALS LTD. (CSE: NINE) (OTC Pink: VMSXF) (FSE: KQ9) (the "Company" or "Nine Mile") is pleased to announce Certified Assay results for volcanogenic massive sulphide (VMS) mineralization collected from the pre-drill area on the Wedge VMS Project, in the world-famous Bathurst Mining Camp (BMC), New Brunswick, Canada.TABLE 1: ACTLABS CERTIFIED ASSAY RESULTS:Sample #CuPbZnAuAgCu Eq%%%g/tg/t%28044710.900.020.040.176.0011.222804489.950.030.030.24 ...

Oil prices jumped on Monday on potential disruptions in oil supply from the Middle East. At the time of writing, the price of West Texas Intermediate crude oil was at $58 per barrel, up 2.2%, while B... ...

公司战略与领导层调整 - 公司宣布领导层晋升，旨在调整组织以迎接下一阶段增长，并将2026年定位为企业级人工智能创新在其平台上的关键一年 [1] - 自2026年1月1日起，A Hadi Chaudhry将担任首席战略官，负责企业人工智能愿景、平台创新和全公司人工智能计划 Stephen Snyder将担任首席执行官，继续专注于纪律性执行、财务表现、利润率扩张，并在门诊和医院市场推广公司的人工智能解决方案 [2] - 此次领导层演变反映了公司向更注重执行的运营模式转变，同时将高级领导层的精力用于加速人工智能发展，以建立长期竞争优势 [3] 运营与财务表现 - 公司在过去几年建立了强劲的发展势头，扩大了利润率，加强了财务基本面，并成功进入了医院软件市场 [4] - 过去两年，公司显著加强了运营和财务基础，实现了显著的利润率扩张，改善了现金流稳定性，并有望实现上市以来的首个年度每股收益为正 [4] - 在此期间，公司通过收购Medsphere Systems和HFMA MAP App进入住院患者软件市场，将其业务范围扩展到整个护理连续体，并实质性地扩大了可寻址市场 [4] 管理层观点与未来展望 - 执行董事会主席Mahmud Haq表示，此次领导层调整使管理层能够更专注地执行，并将2026年定位为在整个CareCloud平台上扩展企业人工智能的关键一年 [4] - 首席执行官Stephen Snyder表示，其优先事项将保持为纪律性执行——扩展人工智能驱动的增长、扩大利润率并为股东创造可持续价值 [5] - 首席战略官A Hadi Chaudhry表示，人工智能正在迅速重塑医疗保健运营，其重点将是推进企业人工智能平台，加速解决方案创新，并确保公司保持在将人工智能应用于现实世界医疗工作流程的前沿，并相信2026年将是其客户群采用人工智能的一个主要拐点 [5] 公司业务概览 - CareCloud是一家医疗保健技术和人工智能解决方案的领导者，为超过40,000家医疗服务提供者提供服务，帮助他们改善患者护理，同时减少行政负担和运营成本 [6] - 公司的人工智能和技术解决方案套件帮助客户提高财务和运营绩效，简化临床工作流程并改善患者体验 [6] - 公司的产品和服务包括收入周期管理、实践管理、电子健康记录、商业智能、患者体验管理和数字健康 [6]

BUKIT MERTAJAM, MALAYSIA, Dec. 29, 2025 (GLOBE NEWSWIRE) -- CCH Holdings Ltd (Nasdaq: CCHH) (“CCH” or the “Company”), a Malaysia-based specialty hotpot restaurant chain, today said it expects in 2026 to announce a series of positive corporate developments, including the acquisition of multiple Malaysian restaurant chains, the introduction of new business ventures in Malaysia, and the expansion of the Company’s business to the U.S. and Africa. These anticipated milestones are expected to help the Company gro ...

BURLINGTON, Mass., Dec. 29, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta's B Medical Systems business to THELEMA S.À R.L., for a purchase price of US$63 million. The transaction is expected to close on or before March 31, 2026. "The agreement to sell B Medical Systems marks a major step forward in simplifying the portfolio to prioritize our core capabilities with the highest strategic impact," ...

CUPERTINO, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the Sachs 9th Annual Neuroscience Innovation Forum, taking place January 11, 2026, in San Fran ...

-- Global Expansion Delivers Significant Progress, Operational Efficiency Substantially Enhanced TOKYO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Tokyo Lifestyle Co., Ltd. (Nasdaq: TKLF) (“Tokyo Lifestyle” or the “Company”), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products, collectible cards, trendy toys as well as other products in Hong Kong, Japan, North America, Thailand, Vietnam, the United Kingdom and Australia, today announced that Mr. Mei ...

VANCOUVER, BC, Dec. 29, 2025 /PRNewswire/ - BTQ Technologies Corp. ("BTQ" or the "Company") (Nasdaq: BTQ) (CBOE CA: BTQ) (FSE: NG3), a global quantum technology company focused on securing mission-critical networks, today issued a Year-End Letter to Shareholders from its Chief Executive Officer and Chairman, Olivier Roussy Newton. Dear Shareholders, As we close 2025, I want to reflect on a year defined by one thing: turning the "quantum era" from a future headline into deployment, standards leadership, and ...